Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
AKTIENPREIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership296,482 shares
Latest Disclosed Value $ 6,341,750
UBS Group AG ownership in PDC / Pediatrix Medical Group, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 296,482 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $5,336,676 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 585,750 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of -49.38% during the quarter. The current value of the position is $5,544,213 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PDC) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:PDC / Pediatrix Medical Group, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 296,482 -289,268 -49.38 6,342 -49.39 0.0002
2026-01-29 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 585,750 276,646 89.50 12,529 142.01 0.0004
2025-11-13 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 309,104 -102,521 -24.91 5,177 -12.34 0.0008
2025-08-14 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 411,625 270,255 191.17 5,907 188.38 0.0010
2025-05-13 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 141,370 3,668 2.66 2,048 13.40 0.0004
2025-02-14 2024-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 137,702 74,668 118.46 1,807 147.40 0.0003
2024-11-14 2024-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 63,034 -147,427 -70.05 731 -54.03 0.0002
2024-08-14 2024-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 210,461 119,229 130.69 1,589 73.55 0.0004
2024-05-13 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 91,232 33,238 57.31 915 69.76 0.0002
2024-02-09 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 57,994 20,111 53.09 539 12.06 0.0002
2023-11-09 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 37,883 -44,786 -54.18 481 -59.03 0.0002
2023-08-11 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 82,669 -23,555 -22.17 1,175 -25.84 0.0004
2023-05-12 2023-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 106,224 24,435 29.88 1,584 30.29 0.0006
2023-02-08 2022-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 81,789 24,069 41.70 1,215 27.49 0.0005
2022-11-10 2022-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 57,720 48,195 505.98 953 376.50 0.0004
2022-08-10 2022-06-30 13F MEDNAX COM 58502B106 9,525 -30,561 -76.24 200 -78.75 0.0001
2022-05-16 2022-03-31 13F MEDNAX COM 58502B106 40,086 -13,209 -24.78 941 -35.10 0.0003
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 53,295 21,313 66.64 1,450 59.52 0.0004
2021-11-15 2021-09-30 13F MEDNAX COM 58502B106 31,982 -20,197 -38.71 909 -42.21 0.0003
2021-08-13 2021-06-30 13F MEDNAX COM 58502B106 52,179 -20,558 -28.26 1,573 -15.11 0.0005
2021-05-12 2021-03-31 13F MEDNAX COM 58502B106 72,737 -33,306 -31.41 1,853 -28.79 0.0006
2021-02-11 2020-12-31 13F MEDNAX COM 58502B106 106,043 19,530 22.57 2,602 84.80 0.0009
2020-11-12 2020-09-30 13F MEDNAX COM 58502B106 86,513 77,843 897.84 1,408 851.35 0.0005
2020-07-31 2020-06-30 13F MEDNAX COM 58502B106 8,670 -45,980 -84.14 148 -76.73 0.0001
2020-05-01 2020-03-31 13F MEDNAX COM 58502B106 54,650 47,839 702.38 636 236.51 0.0003
2020-02-14 2019-12-31 13F MEDNAX COM 58502B106 6,811 -969 -12.46 189 7.39 0.0001
2019-11-14 2019-09-30 13F MEDNAX COM 58502B106 7,780 -116,860 -93.76 176 -94.40 0.0001
2019-08-14 2019-06-30 13F MEDNAX COM 58502B106 124,640 -12,807 -9.32 3,144 -15.82 0.0012
2019-05-14 2019-03-31 13F MEDNAX COM 58502B106 137,447 121,517 762.82 3,735 610.08 0.0015
2019-02-14 2018-12-31 13F MEDNAX COM 58502B106 15,930 -20,554 -56.34 526 -69.10 0.0002
2018-11-14 2018-09-30 13F MEDNAX COM 58502B106 36,484 12,458 51.85 1,702 63.65 0.0007
2018-08-14 2018-06-30 13F MEDNAX COM 58502B106 24,026 -1,940 -7.47 1,040 -27.98 0.0005
2018-05-15 2018-03-31 13F MEDNAX COM 58502B106 25,966 -47,795 -64.80 1,444 -63.37 0.0006
2018-02-14 2017-12-31 13F MEDNAX COM 58502B106 73,761 40,906 124.50 3,942 178.19 0.0016
2017-11-14 2017-09-30 13F MEDNAX COM 58502B106 32,855 -28,294 -46.27 1,417 -61.61 0.0007
2017-11-14 2017-06-30 13F/A-1 MEDNAX COM 58502B106 61,149 17,631 40.51 3,691 22.26 0.0019
2017-08-14 2017-06-30 13F MEDNAX COM 58502B106 61,149 17,631 3,691
2017-11-14 2017-03-31 13F/A-1 MEDNAX COM 58502B106 43,518 -9,448 -17.84 3,019 -14.50 0.0016
2017-05-12 2017-03-31 13F MEDNAX COM 58502B106 43,518 -9,448 3,019
2017-02-14 2016-12-31 13F MEDNAX COM 58502B106 52,966 8,576 19.32 3,531 20.06 0.0019
2016-11-14 2016-09-30 13F MEDNAX COM 58502B106 44,390 -6,134 -12.14 2,941 -19.64 0.0018
2016-08-12 2016-06-30 13F MEDNAX COM 58502B106 50,524 -8,010 -13.68 3,660 -3.23 0.0023
2016-05-12 2016-03-31 13F MEDNAX COM 58502B106 58,534 -58,714 -50.08 3,782 -54.99 0.0025
2016-02-16 2015-12-31 13F MEDNAX COM 58502B106 117,248 51,084 77.21 8,402 65.36 0.0055
2015-11-13 2015-09-30 13F MEDNAX COM 58502B106 66,164 -9,142 -12.14 5,081 -8.96 0.0036
2015-08-14 2015-06-30 13F MEDNAX COM 58502B106 75,306 -80,625 -51.71 5,581 -50.64 0.0037
2015-05-14 2015-03-31 13F MEDNAX COM 58502B106 155,931 5,733 3.82 11,306 13.87 0.0078
2015-02-17 2014-12-31 13F MEDNAX COM 58502B106 150,198 150,198 9,929 0.0069
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-14 2018-09-30 13F MEDNAX COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F MEDNAX COM Call 150,000 50.00 6,492 16.70 n/a n/a n/a
2018-05-15 2018-03-31 13F MEDNAX COM Call 100,000 5,563 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.